Guardant Health (GH) Cost of Revenue (2017 - 2026)

Guardant Health (GH) has 10 years of Cost of Revenue data on file, last reported at $104.9 million in Q1 2026.

• Quarterly Cost of Revenue rose 40.41% year-over-year to $104.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $311.2 million (up 23.87% YoY) and the FY2025 annual result came in at $349.0 million, up 20.43% from the prior year.
• Cost of Revenue rose to $104.9 million in Q1 2026 per GH's latest filing, from -$2.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $127.4 million in Q3 2025, with the low at -$132.7 million in Q4 2023.
• Average Cost of Revenue over 5 years is $59.5 million, with a median of $73.6 million recorded in 2022.
• Year-over-year, Cost of Revenue plunged 262.98% in 2023 and jumped 122.33% in 2024.
• Guardant Health's Cost of Revenue stood at $81.4 million in 2022, then sank by 262.98% to -$132.7 million in 2023, then surged by 122.33% to $29.6 million in 2024, then sank by 107.67% to -$2.3 million in 2025, then surged by 4717.91% to $104.9 million in 2026.
• Business Quant data shows GH's Cost of Revenue at $104.9 million in Q1 2026, -$2.3 million in Q4 2025, and $127.4 million in Q3 2025.